Q Line Biotech Limited has announced that its initial public offering (IPO) will open for subscription on May 21, 2026. The company, which specializes in biotechnology products, aims to raise funds through this public issue to support its expansion plans and reduce debt.
IPO Details
The IPO will remain open until May 23, 2026. The price band for the issue is set at Rs 120 to Rs 125 per equity share of face value Rs 10 each. The minimum lot size for retail investors is 120 shares, requiring an investment of at least Rs 14,400 at the upper end of the price band.
Objectives of the Issue
The proceeds from the IPO will be utilized for funding working capital requirements, capital expenditure for expansion, and repayment of certain borrowings. The company also plans to use a portion of the funds for general corporate purposes.
Company Overview
Q Line Biotech is engaged in the research, development, and manufacturing of biotechnological products, including diagnostic kits and reagents. The company has a strong presence in the domestic market and is looking to expand its footprint internationally.
Financial Performance
For the fiscal year ended March 2025, the company reported a revenue of Rs 45 crore and a net profit of Rs 6 crore. The company has shown consistent growth over the past three years, with a compound annual growth rate (CAGR) of 18% in revenue.
Lead Managers and Registrar
The book-running lead managers for the issue are SBI Capital Markets Limited and Keynote Corporate Services Limited. The registrar for the IPO is Link Intime India Private Limited.
Market Sentiment
Analysts have a positive outlook on the IPO, citing the company's strong product pipeline and growing demand for biotech products in India. The IPO is expected to attract significant interest from both retail and institutional investors.
How to Apply
Investors can apply for the IPO through their bank accounts using the ASBA (Application Supported by Blocked Amount) facility. The shares are proposed to be listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
